Galapagos.
biotechnology company based in Leiden, Netherlands
- Reports this week
- 0
- Active events
- 0
- Connections
- 31
What's happening
Gone quiet
No new reports in 90+ days-
The company Galapagos began using LinkedIn as a platform for information sharing.Some support2 reports
-
Aaron Cox joined Galapagos as CFO, and Dan joined the company's senior team.Some support2 reports
-
Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.Some support1 report
-
Jane Griffiths and Dawn Svoronos were appointed to the board of directors of Galapagos on July 24, 2025.Some support1 report
-
Galapagos NV is based in Mechelen, Belgium, and Gilead Therapeutics holds subscription rights for Galapagos shares.Some support3 reports
-
Galapagos and Takeda entered a collaboration and licensing agreement for TYK2 inhibitor development.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Galapagos
Events traced to Galapagos, step by step, newest firstAround Galapagos this week
News at the entities that move Galapagos most-
Gilead Sciences StructuralGilead Sciences supplied sacituzumab govitecan for a clinical trial on October 22, 2026.Moves Galapagos
-
El Niño Shared contextIndonesia and Malaysia participate in an ASEAN dialogue to address El Niño risks to economic activity, with Bakrie urging protection of logistics.Moves Galapagos
-
Hormuz OperationalMines were struck west of the Strait of Hormuz as Trump aims to prevent Iran from obtaining nuclear weapons, prompting IRGC warnings of retaliation.Moves Galapagos
-
LinkedIn Mentioned togetherPraneeta Pujari announced her departure from Amazon via LinkedIn after serving as Senior Product Manager.Moves Galapagos
-
Europe Shared contextProtests have begun across Europe regarding the lack of funding for schools.Moves Galapagos
-
Netherlands Shared contextThe Dutch East India Company began its maiden voyage from the Netherlands, operating from its headquarters in Java within the Dutch East Indies.Moves Galapagos
Connections
The 11 strongest of 31, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Gilead Structural
Gilead holds subscription rights for Galapagos shares and the two entities maintain a partnership.
-
Gilead Sciences Structural
Galapagos and Gilead Sciences maintain a structural relationship defined by a transformational agreement and board representation.
-
Paul Stoffels Structural
Paul Stoffels served as the CEO and Chair of the Board for Galapagos.
-
LinkedIn Mentioned together
Galapagos utilizes LinkedIn as a professional networking platform for company updates and information dissemination.
-
Seychelles Mentioned together
The entities are co-mentioned as sharing the characteristic of hosting giant tortoises in the wild.
-
Belgium Shared context
Galapagos conducts operations and is based in Belgium, using the country as a positional backdrop for its business activities.
-
Hormuz Operational
The company utilizes the Hormuz Strait as a transit point for its maritime operations, which are currently underway despite ongoing strikes.
-
Europe Shared context
Galapagos operates within the context of Europe's biotech industry.
Show all 11 connections
-
El Niño Shared context
El Niño influences the Galapagos ecosystem through warming waters, decimating natural food sources.
-
International Union for Conservation of Nature Shared context
IUCN classifies species within the Galapagos ecosystem as Vulnerable.
-
Netherlands Shared context
Galapagos is a biotechnology company based in the Netherlands.
History
Events by the month they beganJune 2026
6 events- The company Galapagos began using LinkedIn as a platform for information sharing.
- Aaron Cox joined Galapagos as CFO, and Dan joined the company's senior team.
- Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.
- Jane Griffiths and Dawn Svoronos were appointed to the board of directors of Galapagos on July 24, 2025.
- Galapagos NV is based in Mechelen, Belgium, and Gilead Therapeutics holds subscription rights for Galapagos shares.
- Galapagos and Takeda entered a collaboration and licensing agreement for TYK2 inhibitor development.